John Jefferies - 20 Mar 2026 Form 4 Insider Report for DAXOR CORP (DXR)

Reporting relationship: Chief Medical Officer
Issuer ticker: DXR
Reported as of: 20 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Mar 2026, 17:58:26 UTC
Prior SEC filing: 14 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ John Jefferies

Key filing fact

John Jefferies filed Form 4 for DAXOR CORP (DXR) on 24 Mar 2026.

Key facts

This page summarizes John Jefferies's Form 4 filing for DAXOR CORP (DXR).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 24 Mar 2026, 17:58.

Change

Previous filing in this sequence was filed on 14 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002086843 Primary reporting owner

Jefferies John

Relationship: Chief Medical Officer
Address: 109 MECO LANE, OAK RIDGE
Signature: /s/ John Jefferies
Signature date: 24 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DXR transaction

Daxor Common Stock

Purchase

Transaction value
Shares: +3,656
Change %: +21%
Price: $0.000000^*
Shares after: 21,272
Date: 20 Mar 2026
Ownership: Direct
Footnotes: F1

DXR transaction

Daxor Common Stock

Purchase

Transaction value
Shares: +2,285
Change %: +11%
Price: $0.000000^*
Shares after: 23,557
Date: 20 Mar 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

3,656 shares granted vest on March 20, 2029.

Footnote F2

2,285 shares granted vested on March 20, 2026

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .